Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$99,829
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Love Douglas +$100K PRESIDENT AND CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2020-07-28 Flynn James E 10% owner Conversion +458,914 458,914
2020-07-28 Flynn James E 10% owner Conversion +458,914 458,914
2020-07-28 Flynn James E 10% owner Purchase +350,000 $17.00 $6.0M 808,914
2020-07-28 Flynn James E 10% owner Purchase +350,000 $17.00 $6.0M 808,914
2020-07-28 Flynn James E 10% owner Conversion · Series D Preferred Stock −4,043,032 0
2020-07-28 Flynn James E 10% owner Conversion · Series D Preferred Stock −4,043,031 0
2020-07-28 Bain Capital Life Sciences Investors, LLC 10% owner Conversion +2,522,385 2,522,385
2020-07-28 Bain Capital Life Sciences Investors, LLC 10% owner Conversion +319,243 2,841,628
2020-07-28 Bain Capital Life Sciences Investors, LLC 10% owner Purchase +400,000 $17.00 $6.8M 3,241,628
2020-07-28 Bain Capital Life Sciences Investors, LLC 10% owner Conversion · Series C Preferred Stock −22,222,221 0
2020-07-28 Bain Capital Life Sciences Investors, LLC 10% owner Conversion · Series D Preferred Stock −2,812,543 0
2020-07-23 Overdorf Michael EVP & Chief Business Officer Grant or award · Stock Option (Right to Buy) +242,905 242,905

Page 15 of 15 · 292 trades